GLENMARK PHARMACEUTICALS
|
GLENMARK PHARMACEUTICALS Last 5 Year Balance Sheet History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹28 Cr | ₹28 Cr | ₹28 Cr | ₹28 Cr | ₹28 Cr |
Equity - Authorised | ₹237 Cr | ₹237 Cr | ₹237 Cr | ₹237 Cr | ₹237 Cr |
Equity - Issued | ₹28 Cr | ₹28 Cr | ₹28 Cr | ₹28 Cr | ₹28 Cr |
Equity Paid Up | ₹28 Cr | ₹28 Cr | ₹28 Cr | ₹28 Cr | ₹28 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹1.00 | ₹1.00 | ₹1.00 | ₹1.00 | ₹1.00 |
Share Warrants & Outstandings | ₹18 Cr | ₹18 Cr | ₹16 Cr | ₹22 Cr | ₹14 Cr |
Total Reserves | ₹7,801 Cr | ₹9,428 Cr | ₹9,042 Cr | ₹7,015 Cr | ₹6,029 Cr |
Securities Premium | ₹1,687 Cr | ₹1,685 Cr | ₹1,685 Cr | ₹1,685 Cr | ₹1,685 Cr |
Capital Reserves | ₹0.10 Cr | ₹0.10 Cr | ₹0.10 Cr | ₹0.10 Cr | ₹0.10 Cr |
Profit & Loss Account Balance | ₹7,870 Cr | ₹9,457 Cr | ₹9,211 Cr | ₹7,234 Cr | ₹6,330 Cr |
General Reserves | ₹146 Cr | ₹146 Cr | ₹146 Cr | ₹146 Cr | ₹146 Cr |
Other Reserves | ₹-1,901 Cr | ₹-1,860 Cr | ₹-2,000 Cr | ₹-2,050 Cr | ₹-2,132 Cr |
Reserve excluding Revaluation Reserve | ₹7,801 Cr | ₹9,428 Cr | ₹9,042 Cr | ₹7,015 Cr | ₹6,029 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹7,848 Cr | ₹9,474 Cr | ₹9,087 Cr | ₹7,065 Cr | ₹6,071 Cr |
Minority Interest | ₹-0.38 Cr | ₹365 Cr | ₹351 Cr | ₹-0.35 Cr | ₹-0.39 Cr |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | - | - | - | - | - |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | - | - | - | - | - |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | - | - | - | - | - |
Unsecured Loans | - | ₹3,852 Cr | ₹2,572 Cr | ₹3,889 Cr | ₹4,043 Cr |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | ₹729 Cr | ₹1,017 Cr | ₹1,643 Cr |
Long Term Loan in Foreign Currency | ₹157 Cr | ₹2,806 Cr | ₹2,572 Cr | ₹2,095 Cr | - |
Loans - Banks | - | ₹1,191 Cr | - | ₹1,062 Cr | ₹1,295 Cr |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | ₹1,488 Cr |
Other Unsecured Loan | ₹-157 Cr | ₹-146 Cr | ₹-729 Cr | ₹-286 Cr | ₹-383 Cr |
Deferred Tax Assets / Liabilities | ₹-1,049 Cr | ₹-1,805 Cr | ₹-1,655 Cr | ₹-1,506 Cr | ₹-1,439 Cr |
Deferred Tax Assets | ₹1,432 Cr | ₹2,046 Cr | ₹1,938 Cr | ₹1,823 Cr | ₹1,754 Cr |
Deferred Tax Liability | ₹383 Cr | ₹240 Cr | ₹283 Cr | ₹318 Cr | ₹315 Cr |
Other Long Term Liabilities | ₹692 Cr | ₹575 Cr | ₹352 Cr | ₹421 Cr | ₹429 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | - | - | - | - | - |
Total Non-Current Liabilities | ₹-357 Cr | ₹2,621 Cr | ₹1,270 Cr | ₹2,804 Cr | ₹3,033 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹2,536 Cr | ₹2,000 Cr | ₹2,289 Cr | ₹2,238 Cr | ₹2,126 Cr |
Sundry Creditors | ₹2,536 Cr | ₹2,000 Cr | ₹2,289 Cr | ₹2,238 Cr | ₹2,126 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹1,517 Cr | ₹1,605 Cr | ₹1,446 Cr | ₹886 Cr | ₹1,002 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | - | - | - | - | - |
Interest Accrued But Not Due | ₹4.40 Cr | ₹43 Cr | ₹14 Cr | ₹18 Cr | ₹19 Cr |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹1,513 Cr | ₹1,562 Cr | ₹1,433 Cr | ₹868 Cr | ₹982 Cr |
Short Term Borrowings | ₹833 Cr | ₹350 Cr | ₹370 Cr | ₹513 Cr | ₹443 Cr |
Secured ST Loans repayable on Demands | - | - | - | - | - |
Working Capital Loans- Sec | - | - | - | - | - |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹833 Cr | ₹350 Cr | ₹370 Cr | ₹513 Cr | ₹443 Cr |
Short Term Provisions | ₹932 Cr | ₹591 Cr | ₹585 Cr | ₹564 Cr | ₹556 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹291 Cr | ₹98 Cr | ₹93 Cr | ₹50 Cr | ₹41 Cr |
Provision for post retirement benefits | ₹101 Cr | ₹88 Cr | ₹98 Cr | ₹115 Cr | ₹112 Cr |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹540 Cr | ₹404 Cr | ₹394 Cr | ₹399 Cr | ₹403 Cr |
Total Current Liabilities | ₹5,819 Cr | ₹4,546 Cr | ₹4,689 Cr | ₹4,201 Cr | ₹4,126 Cr |
Total Liabilities | ₹13,309 Cr | ₹17,566 Cr | ₹15,397 Cr | ₹14,069 Cr | ₹13,229 Cr |
ASSETS | |||||
Gross Block | ₹9,620 Cr | ₹10,360 Cr | ₹10,213 Cr | ₹8,732 Cr | ₹8,270 Cr |
Less: Accumulated Depreciation | ₹5,409 Cr | ₹4,938 Cr | ₹4,326 Cr | ₹3,603 Cr | ₹3,241 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹4,210 Cr | ₹5,422 Cr | ₹5,887 Cr | ₹5,129 Cr | ₹5,029 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹419 Cr | ₹1,066 Cr | ₹921 Cr | ₹1,218 Cr | ₹1,091 Cr |
Non Current Investments | ₹790 Cr | ₹45 Cr | ₹50 Cr | ₹25 Cr | ₹25 Cr |
Long Term Investment | ₹790 Cr | ₹45 Cr | ₹50 Cr | ₹25 Cr | ₹25 Cr |
Quoted | ₹745 Cr | ₹0.07 Cr | ₹0.05 Cr | ₹0.07 Cr | ₹0.03 Cr |
Unquoted | ₹45 Cr | ₹45 Cr | ₹50 Cr | ₹25 Cr | ₹25 Cr |
Long Term Loans & Advances | ₹212 Cr | ₹181 Cr | ₹161 Cr | ₹146 Cr | ₹124 Cr |
Other Non Current Assets | ₹7.42 Cr | ₹3.46 Cr | ₹6.70 Cr | ₹28 Cr | ₹26 Cr |
Total Non-Current Assets | ₹5,881 Cr | ₹6,840 Cr | ₹7,115 Cr | ₹6,709 Cr | ₹6,425 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | - | - | - | - | - |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | - | - |
Inventories | ₹2,513 Cr | ₹2,374 Cr | ₹2,500 Cr | ₹2,277 Cr | ₹2,136 Cr |
Raw Materials | ₹580 Cr | ₹649 Cr | ₹703 Cr | ₹528 Cr | ₹635 Cr |
Work-in Progress | ₹103 Cr | ₹84 Cr | ₹402 Cr | ₹439 Cr | ₹361 Cr |
Finished Goods | ₹1,193 Cr | ₹1,020 Cr | ₹846 Cr | ₹839 Cr | ₹725 Cr |
Packing Materials | ₹314 Cr | ₹298 Cr | ₹269 Cr | ₹230 Cr | ₹193 Cr |
Stores  and Spare | ₹111 Cr | ₹114 Cr | ₹104 Cr | ₹107 Cr | ₹85 Cr |
Other Inventory | ₹213 Cr | ₹209 Cr | ₹174 Cr | ₹133 Cr | ₹136 Cr |
Sundry Debtors | ₹1,858 Cr | ₹3,665 Cr | ₹3,101 Cr | ₹2,572 Cr | ₹2,409 Cr |
Debtors more than Six months | ₹396 Cr | ₹363 Cr | ₹302 Cr | ₹396 Cr | - |
Debtors Others | ₹1,593 Cr | ₹3,443 Cr | ₹2,929 Cr | ₹2,283 Cr | ₹2,505 Cr |
Cash and Bank | ₹1,659 Cr | ₹1,160 Cr | ₹1,412 Cr | ₹1,139 Cr | ₹1,111 Cr |
Cash in hand | ₹0.98 Cr | ₹1.04 Cr | ₹1.69 Cr | ₹1.61 Cr | ₹1.66 Cr |
Balances at Bank | ₹1,658 Cr | ₹1,159 Cr | ₹1,410 Cr | ₹1,138 Cr | ₹1,110 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹178 Cr | ₹317 Cr | ₹297 Cr | ₹671 Cr | ₹603 Cr |
Interest accrued on Investments | - | - | - | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | ₹27 Cr | ₹227 Cr | ₹220 Cr | ₹220 Cr | ₹146 Cr |
Other current_assets | ₹152 Cr | ₹89 Cr | ₹78 Cr | ₹451 Cr | ₹458 Cr |
Short Term Loans and Advances | ₹1,219 Cr | ₹908 Cr | ₹972 Cr | ₹700 Cr | ₹544 Cr |
Advances recoverable in cash or in kind | ₹526 Cr | ₹382 Cr | ₹457 Cr | ₹633 Cr | ₹508 Cr |
Advance income tax and TDS | - | - | - | - | ₹2.65 Cr |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹693 Cr | ₹526 Cr | ₹516 Cr | ₹68 Cr | ₹34 Cr |
Total Current Assets | ₹7,428 Cr | ₹8,424 Cr | ₹8,282 Cr | ₹7,360 Cr | ₹6,804 Cr |
Net Current Assets (Including Current Investments) | ₹1,609 Cr | ₹3,877 Cr | ₹3,593 Cr | ₹3,159 Cr | ₹2,678 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹13,309 Cr | ₹17,566 Cr | ₹15,397 Cr | ₹14,069 Cr | ₹13,229 Cr |
Contingent Liabilities | ₹1,063 Cr | ₹337 Cr | ₹361 Cr | ₹384 Cr | ₹271 Cr |
Total Debt | ₹991 Cr | ₹4,348 Cr | ₹3,670 Cr | ₹4,687 Cr | ₹4,869 Cr |
Book Value | - | 335.13 | 321.45 | 249.60 | 214.65 |
Adjusted Book Value | 277.46 | 335.13 | 321.45 | 249.60 | 214.65 |
Compare Balance Sheet of peers of GLENMARK PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK PHARMACEUTICALS | ₹41,680.9 Cr | -6.9% | -0.2% | 70.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹421,527.0 Cr | -3.7% | -2.5% | 31.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,037.0 Cr | 2.3% | 2.1% | 46.9% | Stock Analytics | |
CIPLA | ₹116,854.0 Cr | -3.2% | 0% | 8.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹111,746.0 Cr | -2.4% | 7.3% | 15.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹99,093.9 Cr | 2% | 2.3% | 37.9% | Stock Analytics |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK PHARMACEUTICALS | -6.9% |
-0.2% |
70.3% |
SENSEX | -1.8% |
-6.6% |
7.1% |
You may also like the below Video Courses